Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer

Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT

(2009) Ukihide Tateishi et al.   RADIOLOGY

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

(2008) Lisa K. Dunnwald et al.   JOURNAL OF CLINICAL ONCOLOGY

Is There a Role for Positron Emission Tomography in Breast Cancer Staging?

(2008) Nicole C. Hodgson et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog

(2008) Caius G Radu et al.   NATURE MEDICINE

Detection of Mutations inEGFRin Circulating Lung-Cancer Cells

(2008) Shyamala Maheswaran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning

(2008) Wolfgang A Weber et al.   Nature clinical practice. Oncology

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

(2007) F. Nole et al.   ANNALS OF ONCOLOGY